KRAS and neoplasm: In patients who received surgery, there was no correlation between KRAS mutation status or G12D subtype and surgical parameters such as lymph node status (p = 0.8719, 95% CI 0.6179–2.760) and tumour location (p = 0.9274, RR 1.170 95% CI 0.6013–2.694) (Table 3).